Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'non-small-cell lung cancer' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 729 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roberto Ravasio
      Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

      Farmeconomia e percorsi terapeutici
    2. Sakamoto, J; Teramukai, T; Watanabe, Y; Hayata, Y; Okayasu, T; Nakazato, N; Ohashi, Y
      Mete-analysis of adjuvant immunochemotherapy using OK-432 in patients withresected non-small-cell lung cancer

      JOURNAL OF IMMUNOTHERAPY
    3. Dai, ZY; Lakshmanan, RR; Zhu, WG; Smiraglia, DJ; Rush, LJ; Fruhwald, MC; Brena, RM; Li, B; Wright, FA; Ross, P; Otterson, GA; Plass, C
      Global methylation profiling of lung cancer identifies novel methylated genes

      NEOPLASIA
    4. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Plosker, GL; Hurst, M
      Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer

      PHARMACOECONOMICS
    6. Cuomo, AM; Della Cuna, FSR; Baiardi, P; Torazzo, R; Preti, P; Della Cuna, GR
      Three conventional-drug combination (ifosfamide, carboplatin, etoposide-ICE regimen) in advanced non-small cell lung cancer (NSCLC)

      JOURNAL OF CHEMOTHERAPY
    7. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    8. Nanni, L; Palomba, G; Morelli, F; Piano, A; Simeone, A; D'Alessandro, V; Sirotova, Z; Capuano, G; Rinaldi, B; Lelli, G
      Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer: A phase I-II study

      JOURNAL OF CHEMOTHERAPY
    9. Han, H; Silverman, JF; Santucci, TS; Macherey, RS; dAmato, TA; Tung, MY; Weyant, RJ; Landreneau, RJ
      Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis

      ANNALS OF SURGICAL ONCOLOGY
    10. Brescia, FJ
      Lung cancer - a philosophical, ethical, and personal perspective

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    11. Choy, H
      Taxanes in combined modality therapy for solid tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    12. Saitoh, G; Sugio, K; Ishida, T; Sugimachi, K
      Prognostic significance of p21(waf1), cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

      ONCOLOGY REPORTS
    13. Higashiyama, M; Kodama, K; Yokouchi, H; Takami, K; Nakagawa, H; Imamura, F; Minamigawa, K; Kobayashi, H
      Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: Relation of the in vitro chemosensitive test to clinical response

      ONCOLOGY REPORTS
    14. Changlai, SP; Tsai, SC; Chou, MC; Ho, YJ; Kao, CH
      Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer

      ONCOLOGY REPORTS
    15. Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, A
      Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study

      ONCOLOGY REPORTS
    16. Pritchard, SC; Nicolson, MC; Lloret, C; McKay, JA; Ross, VG; Kerr, KM; Murray, GI; McLeod, HL
      Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy

      ONCOLOGY REPORTS
    17. Ubagai, T; Matsuura, S; Tauchi, H; Itou, K; Komatsu, K
      Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer

      ONCOLOGY REPORTS
    18. Kurakawa, E; Shimamoto, T; Utsumi, K; Hirano, T; Kato, H; Ohyashiki, K
      Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lungcancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    19. Nozaki, I; Tsuji, T; Iijima, O; Ohmura, Y; Andou, A; Miyazaki, M; Shimizu, N; Namba, M
      Reduced expression of REIC/Dkk3 gene in non-small cell lung cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    20. Naruke, M; Abe, Y; Hatanaka, H; Ohnishi, Y; Yamazaki, H; Kijima, H; Nakamura, M; Ueyama, Y; Kobayashi, K
      Interleukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts

      INTERNATIONAL JOURNAL OF ONCOLOGY
    21. Kara, M; Sak, SD; Orhan, D; Kavukcu, S
      Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    22. Mineo, TC; Ambrogi, V; Corsaro, V; Roselli, M
      Postoperative adjuvant therapy for stage IB non-small-cell lung cancer

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    23. Margaritora, S; Cesario, A; Galetta, D; D'Andrilli, A; Macis, G; Mantini, G; Trodella, L; Granone, P
      Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    24. Daniels, JMA; Rijna, H; Postmus, PE; van Mourik, JC
      Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell lung carcinoma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    25. Kristiansen, G; Petersen, YYS; Kaufmann, O; Schluns, K; Dietel, M; Petersen, I
      Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    26. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    27. Laack, E; Mende, T; Benk, J; Chemaissani, A; Scholtze, J; Lorenz, C; Niestroy, A; Dalhoff, K; Muller, T; Walter, T; Durk, H; Edler, L; Hossfeld, DK
      Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

      EUROPEAN JOURNAL OF CANCER
    28. Coudert, B; Anthoney, A; Fiedler, W; Droz, JP; Dieras, V; Borner, M; Smyth, JF; Morant, R; de Vries, MJ; Roelvink, M; Fumoleau, P
      Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group Report

      EUROPEAN JOURNAL OF CANCER
    29. Oka, M; Fukuda, M; Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Soda, H; Takatani, H; Narasaki, F; Nagashima, S; Nakamura, YI; Hayashi, N; Kohno, S
      Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    30. Baron, F; Cueva, J; Grana, B; Curiel, T; Leon, L; Vazquez, F; Candamio, S; Lopez, R
      Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    31. Bunn, PA
      State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer

      ANTI-CANCER DRUGS
    32. Crino, L; Cappuzzo, F
      Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials

      ANTI-CANCER DRUGS
    33. Van Zandwijk, N
      Non-small cell lung cancer neoadjuvant chemotherapy: the benefits of gemcitabine

      ANTI-CANCER DRUGS
    34. Le Chevalier, T
      Multi-targeted antifolate therapy for non-small cell lung cancer and mesothelioma

      ANTI-CANCER DRUGS
    35. Gandara, DR; Lara, PN; Goldberg, Z; Roberts, P; Lau, DHM
      Neoadjuvant therapy for non-small cell lung cancer

      ANTI-CANCER DRUGS
    36. Pavey, SJ; Hawson, GAT; Marsh, NA
      Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma

      BLOOD COAGULATION & FIBRINOLYSIS
    37. Meuwissen, R; Linn, SC; van der Valk, M; Mooi, WJ; Berns, A
      Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

      ONCOGENE
    38. Kloke, O
      Chemotherapy of elderly patients with non-small-cell lung cancer

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    39. Ferrigno, D; Buccheri, G
      Anthropometric measurements in non-small-cell lung cancer

      SUPPORTIVE CARE IN CANCER
    40. Nomori, H; Horio, H; Suemasu, K
      Differentiating early malignant lung tumors from inflammatory nodules to minimize the use of video-assisted thoracoscopic surgery or open biopsy to establish a diagnosis

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    41. Behringer, D; Spyridonidis, A; Fetscher, S; Schmitt-Graff, A; Hogerle, S; Kaiser, R
      Paraneoplastic polyneuropathy preceding the diagnosis of Hodgkin's diseaseand non-small cell lung cancer in a patient with concomitant Borrelia burgdorferi infection

      ANNALS OF HEMATOLOGY
    42. Quddus, AMMZ; Kerr, GR; Price, A; Gregor, A
      Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy

      CLINICAL ONCOLOGY
    43. Snee, M
      Single-agent mitomycin for advanced non-small cell lung cancer

      CLINICAL ONCOLOGY
    44. Vansteenkiste, JF; Vandebroek, JE; Nackaerts, KL; Weynants, P; Valcke, YJ; Verresen, DA; Devogelaere, RC; Marien, SA; Humblet, YP; Dams, NL
      Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine

      ANNALS OF ONCOLOGY
    45. Merimsky, O; Staroselsky, A; Inbar, M; Schwartz, Y; Wigler, N; Mann, A; Marmor, S; Greif, J
      Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    46. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    47. Feliu, J; Martin, G; Lizon, J; Chacon, JI; Dorta, J; de Castro, J; Rodriguez, A; Heras, BS; Torrego, JC; Espinosa, E; Baron, MG
      Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study

      ANNALS OF ONCOLOGY
    48. Gridelli, C; Perrone, F; Nelli, F; Ramponi, S; De Marinis, F
      Quality of life in lung cancer patients

      ANNALS OF ONCOLOGY
    49. Carnaghi, C; Rimassa, L; Garassino, I; Santoro, A
      Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    50. Kagawa, K; Fujitaka, K; Isobe, T; Yamasaki, M; Miyazaki, M; Oguri, T; Kohno, N
      Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion

      INTERNAL MEDICINE
    51. Aratani, T; Narabayashi, I; Komori, T; Utsunomiya, K; Sueyoshi, K; Tachibana, S; Sasaki, S
      Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression levels in non-small cell lung cancer - a preliminary report

      ANNALS OF NUCLEAR MEDICINE
    52. Kshivets, O
      Immune cell and humoral circuit in prediction of non-small cell lung cancer patients survival after complete resections

      JOURNAL OF TUMOR MARKER ONCOLOGY
    53. Salminen, E; Mac Manus, M
      Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer

      ANNALS OF MEDICINE
    54. Lebeau, B; Urban, T; Baud, M; Collon, T; Le Guen, Y; Febvre, M; Touboul, E
      Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer

      REVUE DES MALADIES RESPIRATOIRES
    55. Muller, H; Guadagni, S
      Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    56. Rinaldi, D; Lormand, N; Brierre, J; Cole, J; Barnes, B; Fontenot, F; Buller, E; Rainey, J
      A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3)

      CANCER INVESTIGATION
    57. Erkisi, M; Erkurt, E; Zeren, H; Tunali, C; Kocabas, A; Burgut, R
      Anticipated administration of GM-CSF in the treatment of non small cell lung cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    58. Malayeri, R; Pirker, R; Huber, H
      New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer

      ONKOLOGIE
    59. Plataniotis, GA; Theofanopoulou, MA
      Treatment of inoperable stage III and IV non-small-cell lung cancer: The 'average' radiotherapist's point of view

      ONKOLOGIE
    60. Pletcher, MT; Nobukuni, T; Fukuhara, H; Kuramochi, M; Maruyama, T; Sekiya, T; Sussan, T; Isomura, M; Murakami, Y; Reeves, RH
      Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23

      GENE
    61. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    62. Kurata, T; Tamura, T; Shinkai, T; Ohe, Y; Kunitoh, H; Kodama, T; Kakinuma, R; Matsumoto, T; Kubota, K; Omatsu, H; Nishiwaki, Y; Saijo, N
      Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    63. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    64. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    65. Tsuchiya, S; Ohe, Y; Sugiura, T; Fuwa, N; Kitamoto, Y; Mori, K; Kobayashi, H; Nakata, K; Sawa, T; Hirai, K; Etoh, T; Saka, H; Saito, A; Fukuda, H; Ishizuka, N; Saijo, N
      Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    66. Sim, S; Rosenzweig, KE; Schindelheim, R; Ng, KK; Leibel, SA
      Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    67. Hirota, S; Tsujino, K; Endo, M; Kotani, Y; Satouchi, M; Kado, T; Hishikawa, Y; Obayashi, K; Takada, Y; Kono, M; Abe, M
      Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    68. Rosenzweig, KE; Sim, SE; Mychalczak, B; Braban, LE; Schindelheim, R; Leibel, SA
      Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    69. Mac Manus, MP; Hicks, RJ; Matthews, JP; Hogg, A; McKenzie, AF; Wirth, A; Ware, RE; Ball, DL
      High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    70. Jeremic, B; Shibamoto, Y; Acimovic, L; Milicic, B; Milisavljevic, S; Nikolic, N; Dagovic, A; Aleksandrovic, J; Radosavljevic-Asic, G
      Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    71. Mehta, M; Scrimger, R; Mackie, R; Paliwal, B; Chappell, R; Fowler, J
      A new approach to dose escalation in non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    72. Mukohara, T; Takeda, K; Miyazaki, M; Takifuji, N; Terakawa, K; Negoro, S
      Japanese experience with second-line chemotherapy with low-dose (60 mg/m(2)) docetaxel in patients with advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    73. Takeda, K; Negoro, S; Takifuji, N; Nitta, T; Yoshimura, N; Terakawa, K; Fukuoka, M
      Dose escalation study of irinotecan combined with carboplatin for advancednon-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    74. Herbst, RS; Lynch, C; Vasconcelles, M; Teicher, BA; Strauss, G; Elias, A; Anderson, I; Zacarola, P; Dang, NH; Leong, T; Salgia, R; Skarin, AT
      Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    75. Dowlati, A; Levitan, N; Gordon, NH; Hoppel, CL; Gosky, DM; Remick, SC; Ingalls, ST; Berger, SJ; Berger, NA
      Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    76. Depierre, A; Westeel, V; Jacoulet, P
      Preoperative chemotherapy for non-small cell lung cancer

      CANCER TREATMENT REVIEWS
    77. Leyton, J; Garcia-Marin, LJ; Tapia, JA; Jensen, RT; Moody, TW
      Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells

      CANCER LETTERS
    78. Skrickova, J; Spelda, S; Kaplanova, J
      The limits of surgical treatment of non-small cell lung cancer

      ACTA MEDICA AUSTRIACA
    79. Tjan-Heijnen, VCG; Groen, HJM; Schramel, FMNH; Stoter, G
      Consensus conference on palliative treatment of stage IV non-small cell lung cancer - Consensus Meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis

      NETHERLANDS JOURNAL OF MEDICINE
    80. Ampil, FL; Chin, HW
      Palliative radiotherapy for synchronous bilateral lung cancers

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    81. Foukas, PG; Tsilivakos, V; Zacharatos, P; Mariatos, G; Moschos, S; Syrianou, A; Asimacopoulos, PJ; Bramis, J; Fotiadis, C; Kittas, C; Gorgoulis, VG
      Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs)and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?

      ANTICANCER RESEARCH
    82. Kimura, T; Kudoh, S; Hirata, K; Takifuji, N; Negoro, S; Yoshikawa, J
      Prognostic factors in elderly patients with unresectable non-small cell lung cancer

      ANTICANCER RESEARCH
    83. van Tinteren, H; Hoekstra, OS; Smit, EF; Verboom, P; Boers, M
      Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography

      CONTROLLED CLINICAL TRIALS
    84. Zips, D; Taha, M; Platzbecker, H; Baumann, M; Herrmann, T
      Obstruction of the esophagus 5 months after radiotherapy for a central lung cancer

      STRAHLENTHERAPIE UND ONKOLOGIE
    85. von Lieven, H; Burkhardt, E
      Postoperative radiotherapy of NSCLC - Outcome after (3)-D treatment planning

      STRAHLENTHERAPIE UND ONKOLOGIE
    86. Jin, ML; Inoue, S; Umemura, T; Moriya, J; Arakawa, M; Nagashima, K; Kato, H
      Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

      LUNG CANCER
    87. Ushijima, C; Tsukamoto, S; Yamazaki, K; Yoshino, I; Sugio, K; Sugimachi, K
      High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression

      LUNG CANCER
    88. Anacak, Y; Mogulkoc, N; Ozkok, S; Goksel, T; Haydaroglu, A; Bayindir, U
      High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer

      LUNG CANCER
    89. Novello, S; Galli, L; Antonuzzo, A; Crino, L; Pozzi, E; Selvaggi, G; Ricci, S; Marrocolo, F; Darwish, S; Sorbolini, S; Tonato, M; Scagliotti, GV
      Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer

      LUNG CANCER
    90. Clark, JI; Kancharla, K; Qamar, R; Fisher, S; Hantel, A; Panganiban, J; Millbrandt, L; Albain, KS
      Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer

      LUNG CANCER
    91. Langer, CJ
      The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer

      LUNG CANCER
    92. Jelic, S; Mitrovic, L; Radosavljevic, D; Elezar, E; Babovic, N; Kovcin, V; Tomasevic, Z; Kovacevic, S; Gavrilovic, D; Radulovic, S
      Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

      LUNG CANCER
    93. van Dijck, JAAM; Festen, J; de Kleijn, EMHA; Kramer, GWPM; Tjan-Heijnen, VCG; Verbeek, ALM
      Treatment and survival of patients with non-small cell lung cancer stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands

      LUNG CANCER
    94. Ichinose, Y; Kato, H; Koike, T; Tsuchiya, R; Fujisawa, T; Shimizu, N; Watanabe, Y; Mitsudomi, T; Yoshimura, M
      Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the JapanClinical Oncology Group to plan for clinical trials

      LUNG CANCER
    95. Sasaki, H; Moriyama, S; Yukiue, H; Kobayashi, Y; Nakashima, Y; Kaji, M; Fukai, I; Kiriyama, M; Yamakawa, Y; Fujii, Y
      Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer

      LUNG CANCER
    96. Leu, KM; Kim, KM; Larson, M; Larson, M; Schiller, JH
      Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

      LUNG CANCER
    97. Koizumi, T; Tsunoda, T; Fujimoto, K; Nomura, H; Hirai, K; Koyama, S; Okada, K; Kubo, K
      Phase I trial of weekly docetaxel combined with cisplatin in patients withnon-small cell lung cancer

      LUNG CANCER
    98. Graziano, SL; Tatum, A; Herndon, JE; Box, J; Memoli, V; Greene, MR; Kern, JA
      Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study

      LUNG CANCER
    99. Choi, JH; Kim, HC; Lim, HY; Nam, DK; Kim, HS; Yi, JW; Chun, M; Oh, YT; Kang, S; Park, KJ; Hwang, SC; Lee, YH; Hahn, MH
      Vascular endothelial growth factor in the serum of patients with non-smallcell lung cancer: correlation with platelet and leukocyte counts

      LUNG CANCER
    100. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
      Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

      LUNG CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 10:32:51